"Once-weekly semaglutide 24 mg versus once-daily liraglutide 30 mg for weight management (WEGO): a multicentre, double-blind, double-dummy, randomised controlled trial." New England Journal of Medicine, Accessed July 10, 2023, Eli Lilly and Company
Unsurprisingly, following the release of the results, Novo Nordisks stock prices took a sharp drop
Appetite suppression tends to feel strongest during this ramp-up
BioMe The BioMe Biobank, founded in 2007, is an ongoing EHR-linked biorepository that enrolls participants nonselectively from across the Mountain Sinai Health System
Retatrutide is an injectable medication currently being studied for both weight management and type 2 diabetes
While it was initially reported that mice deficient in Insl5 were mildly glucose-intolerant (170), this appears to be age (170) and strain-dependent (164, 168)